Soru

Zorluk: OrtaEndocrinology and Metabolism

Match each laboratory profile with its most likely underlying pathophysiologic diagnosis. Assume normal reference ranges for the following: Serum calcium 8.4-10.2 mg/dL, Phosphorus 2.5-4.5 mg/dL, Intact PTH 15-65 pg/mL.

  • Serum calcium: 12.8 mg/dL, Phosphorus: 2.1 mg/dL, Intact PTH: 8 pg/mLHumoral hypercalcemia of malignancy
  • Serum calcium: 10.9 mg/dL, Phosphorus: 2.4 mg/dL, Intact PTH: 115 pg/mLPrimary hyperparathyroidism
  • Serum calcium: 7.2 mg/dL, Phosphorus: 6.8 mg/dL, Intact PTH: 410 pg/mLSecondary hyperparathyroidism due to chronic kidney disease
  • Serum calcium: 7.6 mg/dL, Phosphorus: 2.0 mg/dL, Intact PTH: 195 pg/mLSecondary hyperparathyroidism due to severe vitamin D deficiency

Cevap

Profile 1 matches Humoral hypercalcemia of malignancy. Profile 2 matches Primary hyperparathyroidism. Profile 3 matches Chronic kidney disease. Profile 4 matches Vitamin D deficiency.
Each underlying diagnosis produces a distinct, predictable pattern of calcium, phosphorus, and parathyroid hormone (PTH) alterations based on physiologic feedback loops. Primary hyperparathyroidism drives high calcium and low phosphorus. Malignancy drives high calcium (suppressing native PTH) and low phosphorus (due to PTHrP). CKD causes low calcium and high phosphorus due to renal failure, triggering high PTH. Vitamin D deficiency causes low calcium and low phosphorus, also triggering high PTH.

Adım Adım Çözüm

1
Analyze the serum calcium level to categorize the primary derangement as hypercalcemia or hypocalcemia.
Profiles 1 and 2 display hypercalcemia, while profiles 3 and 4 display hypocalcemia.
This initial categorization restricts the differential diagnosis to specific subsets of metabolic bone and mineral disorders.
2
Evaluate the intact PTH level relative to the serum calcium to determine if the parathyroid response is appropriate.
In Profile 1, PTH is appropriately suppressed (< 15 pg/mL), indicating a PTH-independent cause of hypercalcemia. In Profile 2, PTH is inappropriately elevated, indicating primary parathyroid pathology. In Profiles 3 and 4, PTH is appropriately elevated in response to hypocalcemia (secondary hyperparathyroidism).
The intact PTH assay is the most reliable tool to differentiate primary hyperparathyroidism from other causes of hypercalcemia, and to confirm an appropriate physiologic response to hypocalcemia.
3
Use the serum phosphorus level to distinguish between the two causes of secondary hyperparathyroidism (Profiles 3 and 4).
Profile 3 shows marked hyperphosphatemia, pointing to chronic kidney disease where the failing kidneys cannot excrete phosphate. Profile 4 shows hypophosphatemia, pointing to vitamin D deficiency where the elevated PTH successfully causes renal phosphate wasting.
Renal function dictates whether the phosphaturic effect of elevated PTH can be achieved.

Anahtar Kavram

Interpretation of paired calcium, phosphorus, and PTH laboratory profiles to differentiate between primary, secondary, and PTH-independent disturbances of mineral metabolism.
Bu soruyu puanla